Xortx Therapeutics Inc (XRTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2017 | 11-2013 | 11-2012 | 11-2011 | 11-2010 | |
| Cash Flows From Operating Activities | |||||
| Net Income | N/A | -21,211 | 17,660 | 28,297 | 139,428 |
| Depreciation Amortization | N/A | 17,817 | 21,090 | 25,811 | 22,105 |
| Income taxes - deferred | N/A | 16,387 | -2,541 | 1,438 | N/A |
| Accounts receivable | N/A | 42,082 | 67,825 | 8,753 | -84,004 |
| Accounts payable and accrued liabilities | N/A | -15,064 | -86,571 | 15,162 | 59,178 |
| Other Working Capital | N/A | 50,387 | -19,375 | 42,960 | -95,884 |
| Other Operating Activity | 0 | -23,860 | 27,645 | -15,489 | 18,833 |
| Operating Cash Flow | $N/A | $66,538 | $25,733 | $106,932 | $59,656 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | -17,161 | -15,212 | -20,232 | -20,328 |
| Net Acquisitions | N/A | N/A | N/A | -7,433 | -4,908 |
| Purchase Sale Intangibles | N/A | -1,355 | -3,500 | -4,700 | N/A |
| Other Investing Activity | 0 | -1,355 | -3,500 | -4,700 | 0 |
| Investing Cash Flow | $N/A | $-18,516 | $-18,712 | $-32,365 | $-25,236 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | N/A | -2,374 | 2,374 |
| Common Stock Issued | N/A | 30 | 661 | 3,344 | 2,113 |
| Common Stock Repurchased | N/A | N/A | -13,600 | -32,290 | N/A |
| Dividend Paid | N/A | -62,234 | -9,538 | -1,459 | N/A |
| Financing Cash Flow | $N/A | $-62,204 | $-22,477 | $-32,779 | $4,487 |
| Beginning Cash Position | N/A | 117,174 | 132,630 | 90,842 | 51,935 |
| End Cash Position | N/A | 102,992 | 117,174 | 132,630 | 90,842 |
| Net Cash Flow | $N/A | $-14,182 | $-15,456 | $41,788 | $38,907 |
| Free Cash Flow | |||||
| Operating Cash Flow | N/A | 66,538 | 25,733 | 106,932 | 59,656 |
| Capital Expenditure | N/A | -17,161 | -15,212 | -20,232 | -20,328 |
| Free Cash Flow | 0 | 49,377 | 10,521 | 86,700 | 39,328 |